Novel drug may help treat hair loss
Scientists identified WAY-316606, a drug originally developed for osteoporosis, that promotes human hair growth by antagonising SFRP1, a brake on hair follicle development. In organ-culture tests using scalp follicles from over 40 patients, WAY-316606 stimulated hair growth similarly to Cyclosporine A, suggesting a potential non-immunosuppressive therapy for androgenetic alopecia pending clinical trials.